American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Risk of Incident Psychosis and Mania With Prescription Amphetamines
Lead: Risk of Incident Psychosis and Mania With Prescription Amphetamines
Lead: Risk of Incident Psychosis and Mania With Prescription Amphetamines
Tuesday 24th September 2024
Explore the risks of psychosis and mania with prescription amphetamines and other key addiction medicine updates in this episode.
7 minutes
Informative
Educational
Supportive
Engaging
Honest
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
159 (View all)
Do you want to link to this podcast?
Get the buttons here!Prescription Amphetamines: Risk of Psychosis and Mania
Episode Overview
- High doses of prescription amphetamines significantly increase the risk of psychosis or mania.
- Instagram ads with FDA health warnings receive less engagement, suggesting stricter regulations could reduce youth interaction.
- Reducing beer serving sizes can lead to a decrease in overall alcohol consumption.
- New estimates show a significant decline in opioid use disorder prevalence between 2016 and 2019.
- Universal naloxone dispensing by paediatricians could help combat rising overdose deaths among youth.
High doses of amphetamines are associated with a 5.28-fold increase in the odds of psychosis or mania
This episode of 'This Week in Addiction Medicine' is packed with critical updates and studies from the field of addiction medicine. Hosted by Zach Caruso, the episode kicks off with a significant study from the American Journal of Psychiatry examining the risk of psychosis and mania associated with prescription amphetamines.
The study found that high doses of amphetamines are linked to a 5.28-fold increase in the odds of experiencing psychosis or mania, highlighting the need for cautious prescribing practices and regular screening for symptoms. You'll find this topic particularly engaging if you're concerned about the mental health impacts of prescription medications. Next up, the episode covers a study on Instagram advertisements for synthetic nicotine products.
It turns out that posts adhering to FDA health warning guidelines received fewer comments, suggesting that stricter regulations could reduce youth engagement with these products. This is followed by an intriguing study on beer sales in England, which discovered that reducing the serving size of draft beer led to a notable decrease in overall alcohol consumption.
The episode also revisits opioid use disorder (OUD) prevalence estimates in the U.S., providing new insights that suggest a significant decline in OUD between 2016 and 2019. Additionally, it reviews interventions for tobacco addiction, finding that a combination of pharmacotherapies and behavioural interventions are most effective for smoking cessation. A poignant discussion on the role of paediatricians in overdose prevention advocates for universal naloxone dispensing to combat rising overdose deaths among youth.
The episode wraps up with a narrative review questioning the diagnosis of substance-induced psychosis, arguing for more comprehensive treatment approaches that consider other risk factors beyond substance use. If you're interested in staying updated on addiction medicine or work in healthcare, this episode offers valuable information and thought-provoking discussions. Tune in to learn more about these pressing issues and what they mean for treatment and prevention strategies.